5% Discrepancy Line a Bad Surprise, FPMAJ Exec Says Drug Prices Will Now Go Down at Double Speed with Annual Re-Pricing

FPMAJ Director General Toshihiko Miyajima The pharma industry was “stunned” by the unexpectedly broad product coverage agreed upon for Japan’s first “off-year” re-pricing in April 2021, Toshihiko Miyajima, director general of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ),...read more